inp.polri.go.id - Jakarta. The Food and Drug Monitoring Agency (BPOM) continues to strengthen the capacity of national laboratories through infrastructure development and expanded international collaboration. This step is being taken to improve global recognition of laboratory testing results while ensuring the safety of drug and food products distributed in Indonesia.
The Head of BPOM, Taruna Ikrar, stated that laboratory development will be carried out in stages with funding support from the Asian Development Bank (ADB). This strengthening will not only focus on Jakarta but will also reach various regions in Indonesia.
"With ADB funding support, we will expand laboratories to reach from Sabang to Merauke. This strengthening is to improve the testing capacity of BPOM laboratories throughout Indonesia," said the Head of BPOM on Monday (7/6/2026).
However, according to him, strengthening domestic laboratories alone is not enough. BPOM must also build networks with international laboratories to foster mutual trust and recognition of test results.
"Our laboratories must be connected to the outside world. Because that's where mutual trust comes from," said Taruna.
He revealed that BPOM has established various collaborations with several global regulatory authorities, including the U.S. The Food and Drug Administration, as well as related institutions in India, China, Japan, and several countries in the Asian region.
According to him, this interconnection is crucial because of the imported products that came to Indonesia. Meanwhile, domestic products are also being pushed to penetrate the international market.
"We want our laboratories to be globally connected across five continents because products from five continents enter Indonesia. Then, our products will also be distributed across five continents," said the Head of BPOM.
He explained that strengthening the global laboratory network encourages green laboratory innovation while improving the capacity and reputation of BPOM laboratories. International recognition is expected to strengthen public trust in the safety, quality, and efficacy of drugs and food.
(ad/ndt/pr/rs)
